The multicenter study will examine efficacy of the Synergy Disc vs. anterior cervical discectomy and fusion in patients with degenerative disc disease.
Following acquisition of parent company FH Ortho, Spine Innovations is fully independent and dedicated to worldwide sales deployment of ESP disc replacements.
Astura Medical was granted FDA 510(k) clearance to market the Dolomite Stand-Alone Anterior Cervical Stabilization System.
Dolomite is the company's third technology providing a combined interbody and fixation option to receive 510k approval within the last 6 months....
Simplify Disc is designed for MRI compatibility, physiologic motion and anatomical height-matching to improve patient outcomes and expand treatment options.
Eeric Truumees, M.D., First Vice President of NASS' Board of Directors, is optimistic that the online virtual annual meeting event in October will allow attendees to benefit from broader input in smaller doses.
Using NanoMetalene Technology, Reef Topography and a TruProfile plating system, Shoreline RT provides complete intraoperative choices for spinal fusion.
The company's sales accelerated through 2Q20 and grew in the high single digits in July, but it cautioned that the new patient pipeline could slow in 2H20.
NuVasive suffered modest impact from COVID-19 in 1Q20 and expects severe reductions in 2Q. However, the company is using its strong cash position to push forward with product development.
Despite supply issues in biologics and flat enabling technology sales, Globus had record revenues in 4Q and a third consecutive year of double-digit growth.
NuVasive's 3Q19 growth was driven by sales of U.S. spinal hardware as the company continues to evangelize adoption of minimally invasive spinal surgery.
Providence Medical Technology closed a US $10.5MM debt agreement that will support distribution of cervical fusion technology in U.S. and ex-U.S. markets.
AxioMed modified terms of a previously-signed 15-year exclusive license agreement with DSM Biomedical, holder of the patent on polymer technology used in AxioMed's viscoelastic disc replacement.
AxioMed announced the first implantation of its viscoelastic Freedom cervical disc in Australia following the late 3Q16 regulatory approval of the device.
DePuy Synthes Spine launched the ZERO-P NATURAL™ Plate, designed for use with the CC Natural allograft spacer, for spinal fusion procedures in the neck.
Study results indicate that patients treated with Spineart's BAGUERA® C cervical disc in 1- or 2-level arthroplasty exhibited good mobility at treated and adjacent levels, disc height restoration and evidence of adjacent level preservation.
Amendia launched the Ceres™ Midline Cervical Plate, intended for anterior screw fixation of the cervical spine as an adjunct to fusion. The system designed for one and two-level surgeries and is available in 18 different length sizes.
Exactech commenced full launch of the Acapella® One Spacer, a cervical cage pre-assembled with integrated anchors to prevent device migration during anterior cervical fusion.
Medtronic commenced U.S. launch of Spine Essentials™, implants and instruments designed to lend efficiency to the most common cervical fusion procedures.
Seven-year follow-up data demonstrated favorable clinical outcomes and patient satisfaction for Medtronic's 2-level Prestige LP™ cervical disc vs. 2-level ACDF.
Medicrea received FDA clearance to market what is reported to be the first-ever patient-specific cervical rod for spine surgery, the UNiD™ Cervical rod.
K2M received FDA 510(k) clearance for expanded indications of its MESA® Mini and DENALI® Mini spinal systems for stabilization of the posterior cervical and thoracic spine as an adjunct to fusion.
Results from 5-year clinical study comparing cervical total disc replacement (LDR's Mobi-C) with anterior discectomy and fusion to treat 2-level degenerative disc disease indicated overall success rates of 61% and 31% for cTDR and ACDF, respectively.
Our site uses cookies to allow easier access for Members and subscribers and to improve our site. You agree to our use of cookies by closing this message box or continuing to use our site.OkRead more